Sage Journals: Discover world-class research

Open access

Research article

First published 2023-1

Achieving no evidence of disease activity-3 in highly active multiple sclerosis patients treated with cladribine and monoclonal antibodies

Ricardo Alonso, Magdalena Casas, Luciana Lazaro [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Open access

Research article

First published 2022-7

Durability of no evidence of disease activity-3 (NEDA-3) in patients receiving cladribine tablets: The CLARITY extension study

Gavin Giovannoni, Barry A Singer, Delphine Issard [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2023-10

Dairy and gluten in disease activity in multiple sclerosis

Isabel A Temperley, Alexandra N Seldon, Madeline AW Reckord [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Open access

Research article

First published 2018

Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-word multicenter experience

Emanuele D’Amico, Aurora Zanghì, Graziella Callari [...]

Therapeutic Advances in Neurological Disorders

Open access

Review article

First published 2022

Inflammasome Activation in Parkinson’s Disease

Shannon Jewell, Ashane M. Herath, Richard Gordon

Journal of Parkinson’s Disease

Free access

Research article

First published 2012-3

Exercise and disease progression in multiple sclerosis: can exercise slow down the progression of multiple sclerosis?

Ulrik Dalgas, Egon Stenager

Therapeutic Advances in Neurological Disorders

Retricted access

Research article

First published 2021-11

Measurement of neurofilaments improves stratification of future disease activity in early multiple sclerosis

Tomas Uher, Eva Kubala Havrdova, Pascal Benkert [...]

Multiple Sclerosis Journal

Open access

Brief report

First published 2019-7

Alemtuzumab following natalizumab in highly active paediatric-onset multiple sclerosis

Monica Margoni, Francesca Rinaldi, Silvia Miante [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Retricted access

Research article

First published 2022-3

The effect of Omega-3 fatty acid supplementation in systemic lupus erythematosus patients: A systematic review

Nina Ramessar, Abhilasha Borad, Naomi Schlesinger

Lupus

Retricted access

Research article

First published 1997-9

The Calpain Hypothesis of Neurodegeneration: Evidence for a Common Cytotoxic Pathway

Raymond T. Bartus

The Neuroscientist

Search results